pis...(put something here)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
lol i got in at .60 earlier and tried to get more in the .59's but I missed it.
ACRS down 87% failure of one of the clinical-stage biopharmaceutical company's two lead programs
BW down 50% third-quarter loss and said it is weighing strategic alternatives for non-core assets.
flipped it yesterday - never even looked at it today
MRVI down 30% misses by $0.02, misses on revs - lowers FY23 guidance
UONE down 36% - Richmond, Virginia, voted down a gambling referendum
how about CEO and CFO exiting? lol
SNBR down 39% - quarterly loss, lowers its guidance
Pink Current Information status now. I see quotes!
now down 82%
VTYX ouch - down 77% Shares of Ventyx Biosciences Inc. (VTYX) plunged 73.7% in premarket trading Tuesday, after the biopharmaceutical company said it has decided not to support further development of its plaque psoriasis and psoriatic arthritis treatments. The stock, which was the biggest decliner listed on major U.S. exchanges ahead of the open, was on track to suffer a record one-day selloff and open in record-low territory. "Although the trial achieved its primary endpoint, the magnitude of efficacy observed did not meet our internal target to support advancement of VTX958 in plaque psoriasis," the company said in a statement. "Accordingly, we will terminate ongoing activities in the Phase 2 plaque psoriasis trial effective immediately." Because of the results, the company decided to also terminate the Phase 2 trial of the psoriatic arthritis treatment. The stock has tumbled 57.3% over the past three months through Monday, while the iShares Biotechnology ETF has lost 5.6% and the S&P 500 has slipped 3.4%. -Tomi Kilgore This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 11-07-23 0715ET Copyright (c) 2023 Dow Jones & Company, Inc.
DISH down 37% earnings miss and ceo leaving
ZNTL down 30% chief scientific officer stepping down and they reported wider loss
BUMBL down 8% ceo leaving
AGL down 20% - loss of $0.08 per share vs ($0.05) FactSet consensus; revenues rose 74.9% year/year to $1.22 bln vs. $1.134 FactSet consensus.
Co issues downside guidance for Q4
FOXF down 33% misses by $0.05, misses on revs; guides Q4 EPS below consensus, revs below consensus
NEXI down 37% - careful they are liquidating
Well they have a lot of brands and their most popular are Vans, North Face, and Timberland. I bought a load of shares on Wed when it really dumped in three of my accounts. I am all out now but that was a great bounce play like the old days.
RELY down 32% company posted a wider-than-expected third-quarter loss
I was just looking at that Buckey. Reminds me of that golf ipo spgc with the 7 employees that moved bigly first few days and now it's a penny stock. Did you look up AIRE? The Platform Services segment offers and develops AI-based products and services to customers in the real-estate industry. Full Time Employees: 9
CFLT bouncing a little here after huge drop on guidance miss - now down 43%
OGN down 11% Organon misses by $0.18, misses on revs; lowers FY23 revs below consensus
Nice bounce on VFC today
I really don't know much about the Expert Market. I don't trade pennies anymore. But I have about three bagholds from way back when and this co is one of those. I must have signed up years ago for filing alerts on this co. Every time they file I get an email that alerts me.
SC 13D/A 11/01/2023 filed
VFC down another buck after earnings miss yesterday and had it dive
WE down 51% on bk fears
KTRA down 79% failure of the company's lead product
8k filed today:
Note: “We”, “Us”, “The Issuer”, and or “The Company” refer to Next Meats Holdings, Inc., a Nevada Company.
Item 3.02 Unregistered Sales of Equity Securities.
On or about September 7, 2023, the Company entered into an agreement for the purchase of 40,168,092 shares of the Company’s restricted Common Stock from Ryo Shirai, a Japanese Citizen and our former Chief Executive Officer, at a price of $0.001 per share of Common Stock. The transaction was completed, and recorded, by the Company’s transfer agent on October 23, 2023, at which time the 40,168,092 resumed the status of Treasury Shares. The total subscription amount paid by the Company was approximately $40,168. At this time, Ryo Shirai is not a related party to the Company.
The aforementioned sale of shares was conducted pursuant to Regulation S of the Securities Act of 1933, as amended ("Regulation S"). The sale of shares was made only to non-U.S. persons/entities (as defined under Rule 902 section (k)(2)(i) of Regulation S), pursuant to offshore transactions, and no directed selling efforts were made in the United States by the issuer, a distributor, any of their respective affiliates, or any person acting on behalf of any of the foregoing.
Following the sale of restricted common shares to the Company, we now have 462,705,290 shares of Common Stock issued and outstanding as of the date of this report.
Item 9.01 Financial Statements and Exhibits.
None.
-2-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Next Meats Holdings, Inc.
Dated: October 31, 2023
By: /s/ Koichi Ishizuka
Koichi Ishizuka,
Chief Executive Officer
Flipped that one yesterday and bought it back again this morning on the dip and flipped it again.
The end of year does make the wash sale a tricky situation. I trade actively and don't let wash sales stop me. Years ago it was a different situation because the brokerages didn't have to report cost basis and wash sales and you were solely responsible for keeping track of wash sales. There actually was a software you could buy to keep track of them - don't quote me but maybe it was gainskeeper? But it is way easier nowadays.
Not really. The wash sale was created to stop people from using it as a way of taking a loss on something that they still want to own. And when they don't allow the loss because you rebought it within the wash-sale time period, they are still allowing you to take that loss but on a delayed basis. They add the loss that you weren't allowed to take to the cost basis of the new shares you bought. So basically you are still taking that loss but later on.
PETS down 29% loss in the second quarter and suspended its divy
Yeah, that's what I would do. So technically they are worthless to you, but they aren't really worthless unless they no longer trade because you can still sell them. That's better for you. I really don't recall what other brokers do in this case. It's been so long since I traded otc's. But I hear you on the Etrade rant. Morgan Stanley has ruined that brokerage. They used to be so much more customer friendly to active traders. Now they nickel and dime you for everything.
Now down 41% - I'll take some here lol
COMM down 22% issues downside guidance
Haven't touched that one and for the exact reason you brought up. The volume stinks.
What would be the point of paying $5 to get rid of a "worthless" security?
-Well, I could think of a few. One that you brought up. If they are penny stocks that you have held for many years the chance of them reversing again and hitting you with another reorg fee are possible. Wouldn't you rather pay $5 to get rid of them then chance a $38 fee down the line? Why can't you just sell them online yourself instead of having Etrade do it? The way it used to work was (and I point this out because they have changed so many rules since MS took them over) if say you sell the entire position, they only charge a commission up to what it was worth. So if your entire position only comes to $3 but you pay $5 commission, they just charge the commission at $3.
-Not sure if theses stocks are actually "worthless." If they are still trading and doing reorg like reverse splits then they are not considered worthless. You could clean up your account and have a nice loss to offset your gains so you don't have to pay any taxes on them. If those losses exceed your gains you can use them each year as a carry over to offset future gains as long as your bottom line doesn't exceed a negative 3k for the year.
If they are truly "worthless" and they are listed under a cusip number you technically need to rid of them the year they officially became worthless. If you didn't do that in the year they became worthless you could always go back and do an amended return - I think you have up to seven years to do that.
Going back to pre MS, I have in the past removed stocks that were listed in my port as a cusip. I thought they would be considered worthless but Etrade figured them in as a total loss on my 1099. Maybe a stock isn't considered totally worthless even when it is under a cusip.
I'm guessing from your description that your stocks aren't truly "worthless" and you can easily use them as a tax loss. Unless you are still following them and you think there is a future event that may catapult them why bother keeping them?
VVOS down 42% after reverse splitting today 1:25